AAAAAA

   
Results: 1-10 |
Results: 10
GROWTH AND DIFFERENTIATION OF BONE-MARROW HEMATOPOIETIC-CELLS IN MICEBEARING EHRLICH ASCITE TUMOR AND TREATED WITH DICYCLOPENTADIENILDICHIOROTITANIUM (IV)
Authors: VALADARES MC KLEIN SI ZYNGIER S QUEIROZ MLS
Citation: Mc. Valadares et al., GROWTH AND DIFFERENTIATION OF BONE-MARROW HEMATOPOIETIC-CELLS IN MICEBEARING EHRLICH ASCITE TUMOR AND TREATED WITH DICYCLOPENTADIENILDICHIOROTITANIUM (IV), International journal of immunopharmacology, 20(10), 1998, pp. 573-581
IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL CLASS OF NONPEPTIDE INHIBITORS OF BLOOD-COAGULATION FACTOR XA
Authors: KLEIN SI CZEKAJ M GARDNER CJ GUERTIN KR CHENEY DL SPADA AP BOLTON SA BROWN K COLUSSI D HERAN CL MORGAN SR LEADLEY RJ DUNWIDDIE CT PERRONE MH CHU V
Citation: Si. Klein et al., IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL CLASS OF NONPEPTIDE INHIBITORS OF BLOOD-COAGULATION FACTOR XA, Journal of medicinal chemistry, 41(4), 1998, pp. 437-450
DESIGN OF A NEW CLASS OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS
Authors: KLEIN SI MOLINO BF CZEKAJ M GARDNER CJ CHU V BROWN K SABATINO RD BOSTWICK JS KASIEWSKI C BENTLEY R WINDISCH V PERRONE M DUNWIDDIE CT LEADLEY RJ
Citation: Si. Klein et al., DESIGN OF A NEW CLASS OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 41(14), 1998, pp. 2492-2502
CONSTRAINED BETA-ALANINE BASED GPIIB IIIA ANTAGONISTS/
Authors: KLEIN SI CZEKAJ M MOLINO BF CHU V
Citation: Si. Klein et al., CONSTRAINED BETA-ALANINE BASED GPIIB IIIA ANTAGONISTS/, Bioorganic & medicinal chemistry letters, 7(13), 1997, pp. 1773-1778
CONFORMATIONALLY FLEXIBLE PLATELET-AGGREGATION INHIBITORS BASED ON THE TETRAPEPTIDE ARG-GLY-ASP-ARG
Authors: KLEIN SI CZEKAJ M MOLINO BF CHU V
Citation: Si. Klein et al., CONFORMATIONALLY FLEXIBLE PLATELET-AGGREGATION INHIBITORS BASED ON THE TETRAPEPTIDE ARG-GLY-ASP-ARG, European journal of medicinal chemistry, 32(10), 1997, pp. 833-839
O-BENZYL HYDROXYPROLINE AS A BIOISOSTERE FOR PHE-PRO - NOVEL DIPEPTIDE THROMBIN INHIBITORS
Authors: KLEIN SI DENER JM MOLINO BF GARDNER CJ DALISA R DUNWIDDIE CT KASIEWSKI C LEADLEY RJ
Citation: Si. Klein et al., O-BENZYL HYDROXYPROLINE AS A BIOISOSTERE FOR PHE-PRO - NOVEL DIPEPTIDE THROMBIN INHIBITORS, Bioorganic & medicinal chemistry letters, 6(18), 1996, pp. 2225-2230
NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS BASED UPON A 4-SUBSTITUTEDPIPERIDINE SCAFFOLD
Authors: KLEIN SI MOLINO BF CZEKAJ M DENER JS LEADLEY RJ SABATINO R DUNWIDDIE CT CHU V
Citation: Si. Klein et al., NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS BASED UPON A 4-SUBSTITUTEDPIPERIDINE SCAFFOLD, Bioorganic & medicinal chemistry letters, 6(12), 1996, pp. 1403-1408
ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST
Authors: BOSTWICK JS KASIEWSKI CJ CHU V KLEIN SI SABATINO RD PERRONE MH DUNWIDDIE CT COOK JJ LEADLEY RJ
Citation: Js. Bostwick et al., ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, Thrombosis research, 82(6), 1996, pp. 495-507
ANTITHROMBOTIC ACTIVITY OF RPR110173, AN ORALLY-ACTIVE PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, IN CANINE MODELS OF ARTERIAL THROMBOSIS
Authors: LEADLEY RJ BOSTWICK JS KASIEWSKI CJ CHU V KLEIN SI CZEKAJ M GARDNER CJ PERRONE MH DUNWIDDIE CT
Citation: Rj. Leadley et al., ANTITHROMBOTIC ACTIVITY OF RPR110173, AN ORALLY-ACTIVE PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, IN CANINE MODELS OF ARTERIAL THROMBOSIS, Circulation, 92(8), 1995, pp. 2329-2329
IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST -RPR-110173
Authors: CHU V SABATINO RD KLEIN SI BIECHY KD LEADLEY RJ BOSTWICK JS KASIEWSKI CJ PERRONE MH DUNWIDDIE CT
Citation: V. Chu et al., IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST -RPR-110173, Blood, 86(10), 1995, pp. 352-352
Risultati: 1-10 |